Sławomir Jeka (Slawomir Jeka)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Rheumatoid Arthritis Patients

Disease Activity

Extracellular Matrix

Idiopathic Pulmonary Fibrosis

Top Venues

Annals of the rheumatic diseases

Mediators of inflammation

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Marcin Stajszczyk, Izabela Obarska, Sławomir Jeka, Bogdan Batko
Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland: real-world evidence using a nationwide database. Annals of the rheumatic diseases (2023)
Marcin Stajszczyk, Sławomir Jeka, Anna Juś, Pawlak-Buś Katarzyna
Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients - the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the clinical response - results from the multicenter observational ACT-POL study. Reumatologia 60 (2) (2022)
Joanna Wielinska, Jerzy Świerkot, Katarzyna Kolossa, Bartosz Bugaj, Monika Chaszczewska-Markowska, Sławomir Jeka, Katarzyna Bogunia-Kubik
Polymorphisms within Genes Coding for IL-17A and F and Their Receptor as Clinical Hallmarks in Ankylosing Spondylitis. Mediators of inflammation 2021 (2021)
Dawid Szwedowski, Joanna Szczepanek, Lukasz Paczesny, Jan Zabrzyński, Maciej Gagat, Ali Mobasheri, Sławomir Jeka
The Effect of Platelet-Rich Plasma on the Intra-Articular Microenvironment in Knee Osteoarthritis. International journal of molecular sciences 22 (11) (2021)